TotalMarketCap

CDT Equity

CDTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$881.470 K

$0.04 -14.93%

Close of 6 Nov 2026

As of 6 Nov 2026, CDT Equity (CDT) has a market capitalization of $881.5K. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$39.2M

Loss-making

Shares outstanding

6,310,778

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

CDT Equity lists more than one class of stock. Company figures above cover all classes combined.

CDTTW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #494Biodexa PharmaceuticalsBDRX$1.26M
  2. #495Artelo BiosciencesARTL$1.16M
  3. #496Matinas BioPharmaMTNB$1.10M
  4. #497CDT EquityCDT$881.5K
  5. #498SciSparcSPRC$869.4K

What if CDT Equity were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,387,066

Per share 32,033,846× higher

Bitcoin $1.53T

$75,051.70

Per share 1,733,296× higher

Apple $5.02T

$246,387.72

Per share 5,690,248× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for CDT Equity are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.